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Abstract
Background—The Health and Safety Practices Survey of Healthcare Workers describes current 
practices used to minimize chemical exposures and barriers to using recommended personal 
protective equipment for the following: antineoplastic drugs, anesthetic gases, high level 
disinfectants, surgical smoke, aerosolized medications (pentamidine, ribavirin, and antibiotics), 
and chemical sterilants.
Methods—Twenty-one healthcare professional practice organizations collaborated with NIOSH 
to develop and implement the web-based survey.
Results—Twelve thousand twenty-eight respondents included professional, technical, and 
support occupations which routinely come in contact with the targeted hazardous chemicals. 
Chemical-specific safe handling training was lowest for aerosolized antibiotics (52%, n = 316), 
and surgical smoke (57%, n = 4,747). Reported employer procedures for minimizing exposure was 
lowest for surgical smoke (32%, n = 4,746) and anesthetic gases (56%, n = 3,604).
Conclusions—Training and having procedures in place to minimize exposure to these 
chemicals is one indication of employer and worker safety awareness. Safe handling practices for 
use of these chemicals will be reported in subsequent papers.
Keywords
web-based survey; cognitive testing; healthcare worker; training; employer safe handling 
procedures; self-report; professional practice organization
INTRODUCTION
Healthcare workers face a number of serious safety and health hazards on the job. In 2012, 
nonfatal injuries and illnesses in the Healthcare and Social Assistance (HCSA) industry 
sector accounted for one out of five incidents surpassing all other private industry sectors 
[BLS, 2013a]. Ergonomic hazards, same level falls, and workplace violence are major 
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contributors to the high rate. Oftentimes overshadowed, chemical hazards also pose an 
established risk to the health of healthcare workers [McDiarmid, 2006; Condon et al., 2009; 
McDiarmid and Leone, 2009]. These include antineoplastic drugs for treating cancer, 
aerosolized medications used in respiratory therapy, high level disinfectants for reusable 
medical and dental devices, anesthetic gases, surgical smoke, chemical sterilants used in 
cold sterilization of medical equipment and supplies, chemicals for cleaning and disinfecting 
of hard non-porous surfaces, and laboratory chemicals [McDiarmid et al., 1993; Winstin, 
1994; Rosenman et al., 2003; Rideout et al., 2005; NIOSH, 2007, 2012; OSHA, 2008, 2013; 
Condon et al., 2009; McDiarmid and Leone, 2009; Connor et al., 2010]. Because limited 
information is available on safe handling practices associated with the use of hazardous 
chemicals, coupled with the fact that the HCSA sector represents over 13% of the workforce 
with the largest projected growth of any industry sector [BLS, 2012, 2013b], the National 
Institute for Occupational Safety and Health (NIOSH) conducted the Health and Safety 
Practices Survey of Healthcare Workers. This hazard surveillance survey provides 
information on the extent and circumstances under which healthcare workers may be 
exposed to chemical agents. The survey presents a cross-section of current practices for 
reducing potential exposures and fills gaps in current knowledge about those practices which 
may guide interventions and future research. The survey focused on selected classes of 
chemical agents including antineoplastic drugs, anesthetic gases, aerosolized medications, 
chemical sterilants, high level disinfectants, and surgical smoke. Chemicals used by 
housekeeping/janitorial services workers to clean and disinfect hard surfaces and those used 
by laboratory workers were not included because we were unable to identify organizations 
through which we could contact these workers. Individual hazard modules were developed 
for each of the chemical hazards included in the survey. Hazard modules included questions 
on hazard-specific training, availability of facility specific safe handling guidelines, 
frequency and duration of chemical use, adherence to recommended safe handling 
guidelines, use of engineering controls and personal protective equipment (PPE), barriers to 
using PPE, and exposure monitoring and medical surveillance (if applicable). In addition to 
the hazard modules, a core module addressed cross-cutting issues and included 
demographic, occupation and employer characteristics.
This article describes methods used to develop and implement the web-based survey of 
healthcare workers. In addition, results are presented on training received in the safe use of 
the respective chemicals and whether the employer had procedures in place for minimizing 
exposure. Findings for each hazard module and core module will be presented separately.
MATERIALS AND METHODS
Survey Instrument Development
A public meeting with healthcare stakeholders representing professional practice 
organizations, industry, labor, and government was convened to seek comments on the 
content and conduct of the survey. These and other comments resulted in substantial 
revisions to the survey instrument. The revised instrument was subsequently reviewed by 
subject matter experts, including representatives of each of the participating professional 
practice organizations, and was further revised. The survey included seven hazard modules 
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and a core module in addition to a screening module (Table I). The survey instrument 
underwent cognitive testing as well as pilot testing of the web instrument. These are 
described below.
Cognitive Interviews
Cognitive interviews are structured, open-ended interviews designed to gather detailed 
information about the thought processes respondents use to understand and answer survey 
questions, instructions, and other content. The purpose of these interviews was to identify 
and remove potential sources of response error. Participants for cognitive interviews were 
recruited from participating professional organizations and screened for assignment to the 
appropriate hazard module based on organizational affiliation. To be eligible to participate, 
the member must have used or been in contact with one or more of the targeted chemical 
hazards in the past 7 calendar days. Approximately 1 week before the interviews, eligible 
participants were mailed a paper survey questionnaire, monetary incentive, and instructions 
for completing and returning the questionnaire prior to scheduled interview.
The cognitive interviews on the seven hazard modules and core module were conducted in 
two rounds. A total of 24 interviewees (3 per module, including core module) participated in 
the first round, and 16 (2 per module) in the second. The interviewees represented 
occupations that would most likely complete a particular hazard module (e.g., respiratory 
therapist—aerosolized medications). Interviews were primarily conducted by phone and 
typically lasted about an hour. Revisions were made after each round of testing.
Development of the Web Survey Instrument
The instrument was subsequently programmed into a proprietary survey software 
application developed by Westat called SurveyBuilder™. The layout, format, and navigation 
of the survey questions were programmed using the latest web survey design principles 
[Couper, 2008; Dillman et al., 2008]. In addition to programming the survey itself, a survey 
home page (Fig. 1) and ancillary introductory pages were created. Hyperlinks to these pages 
contained background information about NIOSH; frequently asked questions; privacy and 
confidentiality statements; disclaimers, and contacts for questions.
Introductory pages (not shown) which followed the home page, included a page for 
participants to enter the Organization Key, a four letter code provided in the survey 
invitation email or web announcement. This code enabled grouping of respondent data by 
professional organization and also programming the first screener question presented to 
respondents.
The remaining introductory pages provided instructions for completing the survey including 
the importance of the screening questions, how to exit and re-enter survey, explanation of 
error messages when a question was skipped, and how a dynamic monthly calendar graphic 
highlighted days corresponding to the time period (described below) of certain questions.
Following the introductory pages, the screening module was presented to determine whether 
respondents were eligible for the survey. Eligible participants included those who indicated 
that they used or came in contact with one or more of the targeted chemical hazards within 
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the past 7 calendar days, or 30 calendar days for the aerosolized medication pentamidine 
which was infrequently administered. The first screener question corresponded to the 
primary hazard module for the respondent's professional organization (Table II), or in the 
case where there was no primary hazard module (e.g., Organization No. 21), the screener 
questions were randomly presented to respondents. The web survey was programmed to 
present only the top two hazard modules even when the respondent indicated they were 
exposed to more than two chemical hazards. The flow diagram in Figure 2 shows 
assignment of hazard modules based on responses to questions in the screening module.
Salient features of the web survey included: (i) programmed skip patterns—respondents 
were only presented with relevant follow-up questions based on their responses to key 
questions; (ii) ability to leave and return to survey at same location where they left off, 
provided it is within 48 hr (otherwise they would need to start from the beginning); (iii) 
prominently displayed error messages alerting respondent when no response was entered; 
and (iv) inclusion of calendar and photos depicting selected engineering controls and 
respirators/surgical masks to minimize response error.
Pilot Testing of the Web Survey Instrument
The primary purpose of the pilot test was to ensure that all aspects of the survey worked 
together by examining how it performed under “live conditions.” The entire web survey 
process was evaluated including contact procedures, respondent access to the web survey via 
a hyperlink from email, entering their Organization Key, web survey functionality and 
administration of the hazard modules, receipt control of completed surveys, and exporting of 
data files into statistical software.
Members of the professional practice organizations were recruited to participate in 
interviews in the same manner as for the cognitive interviews, and assigned appropriate 
hazard modules based on organizational affiliation. All interviews were conducted by 
telephone and concurrently via an internet conference hosting service. Interviewers observed 
respondents’ mouse movements and keystrokes remotely as respondents worked their way 
through the survey. Afterwards, interviewer administered a series of probes that addressed a 
variety of navigation, presentation, and other usability issues. Questions were also asked 
assessing respondents’ willingness to participate, potential participation motivators, overall 
impressions, suggestions for improvement, and any other issues from a healthcare worker's 
perspective. Each interview lasted less than 90 minutes. Participants were compensated for 
their time.
A total of 28 web survey pilot interviews were conducted (4 interviews per module with the 
core module evaluated in conjunction with the hazard modules). Problems identified during 
the pilot testing related to wordiness and imbalanced flow of introductory web pages, 
confusion with the Organization Key and Resume Survey Code, unclear meaning of 
calendar graphic, and confusion with varying timeframes in aerosolized medications 
submodules. Revisions were made to address concerns raised.
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The study population included members of 21 professional practice organizations 
representing healthcare occupations which routinely use or come in contact with one or 
more of the targeted chemical agents. A few hundred candidate professional organizations 
and several labor unions representing healthcare workers were initially contacted to 
determine level of interest and support for the survey. Many of these organizations were not 
eligible or considered for the survey because they: (i) did not maintain email addresses or 
lacked a centralized email list for their members; (ii) indicated that members either did not 
use or were not likely to use any of the chemical agents; (iii) decided not to participate; or 
(iv) did not respond.
Because survey recruitment for individual respondents was by email, the sampling frame 
represented a list of member email addresses maintained by each of the participating 
professional organizations. Each organization sent survey invitation and reminder emails to 
invited members (based on a NIOSH-written template) with an embedded survey link. Some 
organizations which could reliably filter known unexposed members (e.g., directors and 
retirees) further refined their email list. Either a random sample or a census of members was 
invited to participate in the survey, the former being used mainly by organizations with 
>3,000 member emails and the latter by organizations with <3,000 members. All but four 
organizations (Nos. 2, 15, 17, 21) selected a random sample to participate in the survey 
(Table II). Participants were not provided a monetary incentive to participate in the survey.
Survey Implementation
The survey was activated on January 28, 2011 and deactivated on March 29, 2011. The 
survey was accessible 24 hr a day, 7 days a week during this 8 week data collection period. 
Once respondents clicked on the link provided in email from their organization they were 
connected to the survey home page hosted on a secure server. A few weeks after the survey 
was launched, results showed relatively low numbers of participants for the following 
hazard modules: aerosolized medications, antineoplastic drugs (compounding), and 
chemical sterilants. In an effort to increase the number of participants in these and possibly 
other modules, the survey was opened to others, beyond those who were invited by the 21 
partnering organizations, hereafter referred to as non-professional organization respondents. 
They could potentially be from a professional practice organization but were not specifically 
selected in our preliminary process. A survey announcement and link was posted in the 
following locations: NIOSH web pages including e-NEWS; web sites of professional 
occupational health and safety associations, labor unions, other federal agencies; and 
selected listservs. The announcement included a unique organization key which allowed us 
to identify non-professional organization respondents.
Data Analysis
Data were analyzed using SAS 9.3 [SAS, 2010]. Simple frequencies and prevalences are 
presented. In addition, prevalence of training received and reported standard procedures for 
minimizing exposure to hazardous chemicals were stratified by type of employer 
(ambulatory healthcare services or hospital as defined by the North American Industry 
Classification System Codes 621 and 622, respectively [U.S. Census Bureau, 2007]). Those 
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working in other healthcare industries (nursing and residential care facilities, social 
assistance) or non-healthcare industries are excluded from the analysis due to small 
numbers. Chi square and P-value were calculated to determine if a relationship existed 
between (i) training received and (ii) reported standard procedures and the type of employer 
reported by the respondent. These were also calculated excluding non-professional 
organization respondents to determine if their exclusion changed prevalence or Chi square 
P-value.
Human Subjects Review Board
NIOSH Human Subjects Review Board determined that the activities in this project were 
surveillance and did not meet the criteria of research according to 45 CFR 46.1101(b) (2) 




Overall, 12,028 survey respondents were eligible based on screening questions that 
established use/contact with the targeted chemical agents in the past 7 calendar days, or for 
pentamidine the past 30 calendar days, and went on to complete at least one hazard module. 
The numbers of respondents per module and submodule are presented in Table III. Overall, 
survey respondents completed more than 18,000 hazard modules/submodules and almost 
11,000 completed the core module.
Of those who responded to the screener, 488 were eligible but did not continue with the 
survey or were later determined ineligible. Another 10,169 responded to the screener but had 
not been exposed to any chemicals in the time period specified in the questionnaire, so were 
ineligible to participate. Nine percent of respondents were eligible and completed one hazard 
module only; they did not continue on to complete the core module and therefore lack 
demographic information.
Most Prevalent Occupations of Survey Respondents
Table IV presents the occupational groups of respondents who completed the core module. 
Nurses accounted for 55% of the 10,781 respondents who provided their occupation, 
followed by technologists/technicians (14%), physicians (12%), dentists/other dental 
professionals (9%), therapists (7%), pharmacists/other pharmacy professionals (2%). Over 
three-quarters of the nurses were represented by five specialty occupations: nurse 
anesthetist, oncology nurse, operating room nurse, hematology/oncology nurse and 
gastroenterology/endoscopy nurse. Physicians and therapists were almost exclusively 
anesthesiologists and respiratory therapists, respectively. Dentists/other dental professionals 
were primarily: dental hygienists, dentists, and dental assistants. Pharmacists and other 
pharmacy professionals were pharmacists and pharmacy technicians. Most technologists/
technicians were surgical technologists, central supply technicians, and to a lesser extent 
sterilization technicians and radiologic technologists. The majority of respondents in the 
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“other” category were surgical assistants and anesthesiologist assistants; medical assistants 
were also included in this category.
Demographic, Occupational, and Employer Characteristics
Table V presents occupational and employer characteristics of core module respondents. 
Respondents were predominately female (72%), white (91%), 41–55 years of age (46%), 
and had at least a bachelor's degree (61%). Core module respondents spent most of their 
time in direct patient care, over a decade in their current occupation (65%), and lacked 
affiliation with a labor union (89%). Respondents were predominately employed by large, 
non-public hospitals (57% with >249 employees, 88% non-public, 70% hospitals). All 
geographic regions of the U.S were included.
Prevalence of Training and Employer Standard Procedures
Respondents administering aerosolized antibiotics were the least likely to have received 
training on their safe use (48% reported they were never trained), followed closely by those 
exposed to surgical smoke (43% reported they were never trained) (Table VI). Workers 
most likely to have received training were those who administered antineoplastic drugs 
(95%) and those who used hydrogen peroxide gas plasma as a chemical sterilant (92%). Of 
those who administered anesthetic gases, most respondents reported that their training 
occurred more than 12 months earlier (66%). For aerosolized antibiotics, pentamidine, and 
surgical smoke, more respondents were trained over 12 months ago than within the past 12 
months. Training received within the past 12 months was most prevalent for those who 
administered antineoplastic drugs (61%).
The proportion of respondents who reported that their employer had standard procedures for 
minimizing exposure to hazardous chemicals ranged from 32% for those exposed to surgical 
smoke to 94% for those who reported administering antineoplastic drugs (Table VI). For 
anesthetic gases and aerosolized antibiotics, the proportion reporting having procedures was 
slightly over half (56% and55%, respectively). A significant proportion also reported that 
they did not know if their employers had standard procedures; for surgical smoke 40% did 
not know, for anesthetic gases 25% did not know. Those who administered antineoplastic 
drugs were least likely to report that they did not know whether their employer had 
procedures for minimizing employees’ exposure (3%).
Examining hazard-specific training by type of employer, workers compounding 
antineoplastic drugs, handling high level disinfectants, and administering anesthetic gases in 
hospitals were less likely to have been trained than those who used these chemicals and 
worked in ambulatory healthcare services (Table VII). Those who worked with ethylene 
oxide (EtO) were more likely to be trained if they worked in a hospital than in ambulatory 
healthcare services. Few respondents who administered aerosolized medications worked for 
an employer they classified as ambulatory healthcare services, and therefore no comparison 
was done. Removing non-professional organization respondents did not alter the percents or 
P-values for these comparisons.
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Differences existed between respondents who worked for hospitals versus ambulatory 
healthcare services as to whether their employer had standard procedures for minimizing 
exposure to chemical hazards. Those who administered antineoplastic drugs, had contact 
with high level disinfectants, or used EtO and who worked in ambulatory healthcare services 
were less likely to report their employer had standard procedures or they were aware that 
their employer had procedures for minimizing exposure to hazardous chemicals compared to 
hospital employees. Respondents working for hospitals who administered anesthetic gases 
were more likely to report their employer did not have procedures or they were unaware of 
whether their employer had procedures for minimizing their exposure compared to those 
who worked in ambulatory healthcare settings.
DISCUSSION
The Health and Safety Practices Survey of Healthcare Workers represents the largest 
federally sponsored survey of healthcare workers that addresses safety and health practices 
and use of hazardous chemicals. The content of the survey was based on input from a 
diverse group of healthcare stakeholders representing industry, labor, academia, and NIOSH 
researchers. Queried practices included hazard-specific training, employer safe handling 
procedures, use of recommended safe handling guidelines such as engineering controls and 
PPE, and barriers to using PPE. This web-based survey presents a new method for 
surveillance of current occupational practices that captures a wide cross-section of workers 
and workplaces. This type of surveillance can be used to fill in gaps and guide interventions 
and future research to understand whether authoritative guidelines to minimize exposure 
have been adopted in a cross-section of workplaces and insight into why they have not. 
Since the survey was targeted through professional organizations to workers who were 
likely to use these chemicals, we could ask specific questions about recommended practices 
that were relevant to them and obtain a robust response from workplaces diverse in size, 
type, geographic location, and other characteristics. Although our sample was not strictly 
representative of workplace practices across the country, it provides evidence that 
recommended practices have not been universally adopted and workers continue to be 
vulnerable to health consequences. This paper focuses on training and awareness of 
employer safe handling procedures for hazardous chemicals widely used in healthcare.
A report by the NORA Healthcare and Social Assistance Sector Council titled: State of the 
Sector: Healthcare and Social Assistance states that “Recognition and anticipation of 
potential hazards is the first step in preventing work-related illnesses” [Condon et al., 2009]. 
Some of the tools that workers need to recognize and anticipate chemical hazards include 
training and standard procedures for handling them safely. Table VIII provides a partial 
listing of safety and health guidelines developed by government agencies and professional 
organizations. For each class of chemical agent, we asked whether the worker had training, 
the time frame the training took place, and whether their employer had standard procedures 
for handling the chemicals safely.
Although all workers who use or have potential exposure to hazardous chemicals should be 
trained and have procedures for their safe use, these administrative controls were not 
universal for all chemical agents included in this study, most notably for aerosolized 
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antibiotics and surgical smoke. Stakeholders, including respiratory therapists, expressed 
concern over aerosolized antibiotics tobramycin, amikacin, and colistin as well as ribavirin 
and pentamidine as potential respiratory irritants/asthmagens. Ribavirin and pentamidine are 
classified as hazardous drugs and have therefore received more attention from government 
agencies and professional practice organizations including release of precautionary 
guidelines [OSHA, 1999; NIOSH, 2004; ASHP, 2006]. The aerosolized antibiotics included 
in this study have not been classified as hazardous drugs at this time. This may be one 
explanation for why so many respondents who administered aerosolized antibiotics were not 
trained and lacked safe handling procedures. For surgical smoke, we expected many more 
respondents to have received training and have procedures for minimizing exposure since 
exposure control guidelines have been available for many years [NIOSH, 1996; OSHA, 
2008].
Concern over health and safety practices in outpatient work settings have been a concern for 
those handling antineoplastics in the past [Valanis et al., 1992; Martin and Larson, 2003]. 
We looked at employer type (hospital versus ambulatory healthcare services) to see if there 
were differences in whether workers had been trained or had procedures for safe handling of 
the chemicals. In our sample, hospital workers were less likely than those working in 
ambulatory health care settings to be trained on safety practices for compounding 
antineoplastic drugs, using high level disinfectants, and administering anesthetic gases. In 
addition, hospital workers were also less likely to report having procedures for handling 
anesthetic gases than those in ambulatory healthcare settings. A study of workers who 
handled antineoplastic drugs by Valanis et al. [1992] reported that, based on PPE use, 
hospital staff are better protected than workers in outpatient facilities. Our survey found, 
based on employers having safe handling procedures, hospital workers administering 
antineoplastic drugs are still better protected. In addition, hospital workers who administered 
antineoplastic drugs were more likely to report their employer had safe handling procedures 
than those who worked for ambulatory health care settings. Health and safety practices in 
different types of healthcare work settings should be examined further.
This survey has both strengths and limitations. A major strength is that it represents one of 
the largest cross-sectional surveys addressing a wide variety of occupational health and 
safety hazards in a targeted yet diverse healthcare worker population. Best practices such as 
cognitive and pilot testing of the survey instrument were used in the development and 
implementation of the survey. Over 12,000 unique respondents, representing a wide range of 
professional, technical and support occupations, completed the survey (i.e., completed at 
least one hazard module). These respondents completed over 18,000 total hazard modules/
submodules. Survey findings serve as a valuable resource for surveillance of hazards, 
potential exposures, exposure controls and barriers to their use. The data are also expected to 
be useful for priority setting, assessing knowledge gaps, and health and safety promotion.
Several limitations need to be considered. The study population was targeted to professional 
practice organizations whose members are likely to use or come in contact with the chemical 
agents under investigation, but because the invitation was by email and the survey was only 
available via the internet, participants were limited. Survey participants who have resources 
to belong to a professional organization may be more likely to be further along in their 
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career, better paid, more educated, and more aware of health and safety issues and thus may 
not represent all healthcare workers. Response rate cannot be calculated because classes of 
chemical agents under study were specified in the invitation email and eligibility was based 
on whether or not invitees used specific hazardous chemicals on the job; it is unknown who 
decided not to participate because they did not use any of the chemicals versus those who 
used them but decided not to participate for other reasons. Survey findings reflect the 
experiences and practices of the respondents and are not generalizable to all healthcare 
workers or to all members of each of the professional organizations. Demographic 
information was not available for respondents who participated in one hazard module but 
not the core module. Survey data are self-reported by healthcare workers; responses were 
not confirmed via observation, records or other means.
In conclusion, this web-based survey served as a cost-effective surveillance tool to gauge 
current health and safety practices in a population of healthcare workers who would have 
been more difficult to reach by other means. Although the survey data are not generalizable 
to all healthcare workers, the data nevertheless provide valuable insight on the availability of 
training and procedures for minimizing exposure risk as well as other topics.
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Flow diagram showing assignment of hazard modules based on responses to screening 
questions.
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TABLE I
Specific Chemical Agents/Hazards by Module
Module Specific chemical agents/hazards/issues
Aerosolized medications
a Antibiotics amikacin, colistin and tobramycin; pentamidine; ribavirin
Antineoplastic drugs (compound) Numerous specific chemotherapeutic agents
Antineoplastic drugs (administer) Numerous specific chemotherapeutic agents
Chemical sterilants Ethylene oxide, hydrogen peroxide gas plasma
High level disinfectants Glutaraldehyde, orthophthaldehyde, peracetic acid, hydrogen peroxide
Surgical smoke
b
Surgical smoke (generated by laser surgery or electrosurgery
c
 techniques)
Anesthetic gases Desflurane, enflurane, halothane, sevoflurane, nitrous oxide
Core Job-specificchemical, biological, physical agents; work-related injury, illness, exposure in past year; work 
organization (shift work, work hours, overtime, second job hours); physical job demands; hand hygiene 
practices; workplace violence and stress; seasonal influenza vaccination practices; health and safety 
perceptions; demographics
a
Three submodules were developed, one each for aerosolized antibiotics, pentamidine, and ribavirin.
b
Two submodules were developed, one for laser surgery and one for electrosurgery.
c
Includes electrocautery, diathermy, and ultrasonic devices.













Steege et al. Page 16
TABLE II
Primary Hazard Module and Occupation by Professional Organization
Primary hazard module Professional organization Primary occupation of membership
Aerosolized medications No. 1 Respiratory therapist
Antineoplastic drugs (compound) No. 2 Pharmacy technician
No. 3 Pharmacy technician
No. 4 Pharmacist
Antineoplastic drugs (administer) No. 5 Hematology/oncology nurse
No. 6 Infusion nurse
No. 7 Oncology nurse
Chemical sterilants No. 8 Central supply technician/medical supply technician
High level disinfectants No. 9 Dental hygienist
No. 10 Dental assistant
No. 11 Radiologic technologist
No. 12 Surgical technologist
No. 13 Gastroenterology nurse
Surgical smoke No. 14 Perioperative nurse
No. 15 Surgical assistant
Anesthetic gases No. 16 Nurse anesthetist
No. 17 Anesthesiologist assistant
No. 18 Dentist
No. 19 Anesthesiologist
No. 20 Perianesthesia nurse
None
a No. 21 Nurse
a
Several of the hazard modules are relevant.
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TABLE III
Number of Respondents by Module
Hazard module Numbers of respondents
Aerosolized medications 487
    Antibiotics
a 321
    Pentamidine 227
    Ribavirin 50
Antineoplastic drugs (compound) 457
Antineoplastic drugs (administer) 2,069
Chemical sterilants 428
    Ethylene oxide 168
    Hydrogen peroxide gas 347
    Plasma
High level disinfectants 4,657
Surgical smoke 4,752
    Laser surgery 1,469






Includes tobramycin, amikacin, and colistin.
b
Includes electrocautery, diathermy, and ultrasonic procedures.
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TABLE IV
Distribution of Core Module Respondents by Major Occupational Group and Most Prevalent Detailed 
Occupation(s) in These Groups
Major occupational group and most prevalent detailed occupations (n = 10,781) % of total % for each detailed occupation
Nurse 55
    Nurse anesthetist 32
    Oncology nurse 14
    OR nurse 14
    Hematology/oncology nurse 11
    Gastroenterology/endoscopy nurse 10
    Other 19
Technologists/technicians 14
    Surgical technologist 58
    Central supply/processing technician 20
    Sterilization technician 7
    Radiologic technologist 7
    Other 8
Physicians 12
    Anesthesiologist 99
    Other 1
Dentists/other dental professionals 9
    Dental hygienist 44
    General dentist 40
    Dental assistant 13
    Other 3
Therapists 7
    Respiratory therapist 99
    Other 1
Pharmacists/other pharmacy professionals 2
    Pharmacist 59
    Pharmacy technician 40
    Other 1
Other healthcare professionals 2
    Surgical assistant 52
    Anesthesiologist assistant 39
    Other 9
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TABLE V





    Male 28
    Female 72
Race
c (10,420)
    White 91
    Black 4
    Asian 5
    Other 2
Ethnicity (10,527)
    Hispanic 3
Age
b (10,373)
    18–25 years 1
    26–40 years 18
    41–55 years 46
    56–70 years 34
    >70 years 1
Education
b (10,509)
    Grade 12 or less 3
    Vocational certificate 7
    Associate's degree 22
    Bachelor's degree 28
    Master's degree 22
    Doctoral degree/plus 17
Percent of time spent in direct patient care (n)
b (10,749)
    76–100% 70
    51–75% 13
    26–50% 6
    1–25% 7
    No direct patient care 5
Time in current occupation (n)
b (10,722)
    <1 year 3
    1–5 years 17
    6–10 years 15
    11–20 years 25
    >20 years 40
Time with current employer (n)
b (10,753)
    <1 year 7
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Characteristic
a (n) %
    1–5 years 28
    6–10 years 20
    11–20 years 22
    >20 years 23
Employer industry category (n)
b (10,773)
    Ambulatory healthcare services 27
    Hospital 70
    Nursing and residential care 1
    Social assistance/services 2
Size of employer (n)
b (10,712)
    1–9 12
    10–99 22
    100–249 9
    250–1,000 24
    >1,000 33
Employer ownership type (n)
b (10,591)
    For profit 44
    Non-profit 44
    City, county, district, state, fed gov't 9
    Other 3
a
Percents based on number of respondents to individual questions (i.e., number of eligible respondents less number who chose not to answer 
question).
b
Percents may not add up to exactly 100% due to rounding.
c
Percents may add to more than 100% because respondents could select more than one answer.
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TABLE VI
Training and Awareness of Employer Procedures for Working With Hazardous Chemicals
Trained on safe handling/minimizing exposure to these chemicals n ≤12 months ago % >12 months ago % Never %
Aerosolized medications
    Antibiotics: tobramycin, amikacin, colistin 316 22 30 48
    Pentamidine 209 26 49 25
    Ribavirin 49 49 35 16
Antineoplastic drugs
    Compounding 455 45 42 13
    Administration 2,061 61 34 5
Chemical sterilants
    Ethylene oxide (EtO) 167 54 35 11
    Hydrogen peroxide gas plasma 343 51 41 8
High level disinfectants 4,572 48 35 17
Surgical smoke 4,747 25 32 43
Anesthetic gases 3,599 17 66 17
Employer has standard procedures for handling/minimizing exposure to these chemicals n Yes % No % Doesn't know %
Aerosolized medications
    Antibiotics: tobramycin, amikacin, colistin 306 55 25 20
    Pentamidine 210 82 5 13
    Ribavirin 48 81 8 10
Antineoplastic drugs
    Compounding 456 83 7 10
    Administration 2,060 94 3 3
Chemical sterilants
    Ethylene oxide (EtO) 167 92 2 6
    Hydrogen peroxide gas plasma 342 90 3 7
High level disinfectants 4,566 81 5 14
Surgical smoke 4,746 32 28 40
Anesthetic gases 3,604 56 18 25
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TABLE VII
Training and Awareness of Employer Procedures for Working With Hazardous Chemicals by Type of 
Employer: Ambulatory Healthcare Services Or Hospital
Trained on safe handling/minimizing 
exposure to these chemicals
Ambulatory (n) Ambulatory, never 
trained (%)








a 257 48 —
    Pentamidine 15 — 171 23 —
    Ribavirin 3 — 37 14 —
Antineoplastic drugs
    Compounding 250 7 172 16 <0.01
    Administration 716 5 1,181 5 0.77
Chemical sterilants
    Ethylene oxide (EtO) 23 39 131 5 <0.01
    Hydrogen peroxide gas plasma 31 3 289 9 0.29
High level disinfectants 1,339 14 2,423 17 0.02
Surgical smoke 767 43 3,817 44 0.49
Anesthetic gases 824 14 2,524 18 <0.01
Employer has standard procedures 
for handling/minimizing exposure to 
these chemicals
Ambulatory (n) Ambulatory, no 
procedures/
unaware (%)





    Antibiotics: tobramycin, amikacin, 
colistin
11 — 255 45 —
    Pentamidine 16 — 171 15 —
    Ribavirin 3 — 37 16 —
Antineoplastic drugs
    Compounding 251 20 172 13 0.07
    Administration 717 7 1,177 5 0.02
Chemical sterilants
    Ethylene oxide (EtO) 23 30 131 4 <0.01
    Hydrogen peroxide gas plasma 31 10 288 9 0.96
High level disinfectants 1,342 22 2,422 15 <0.01
Surgical smoke 766 69 3,818 68 0.97
Anesthetic gases 827 37 2,525 45 <0.01
a
Dash indicates that due to small numbers no statistic was calculated.
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TABLE VIII
Health and Safety Guidelines for Selected Chemical Hazards
Chemical agent Health and safety guidelines
Aerosolized medications OSHA Technical Manual (OTM) Section VI: Chapter 2: Controlling occupational exposure to hazardous drugs 
https://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html
NIOSH alert on preventing occupational exposures to antineoplastic and other hazardous drugs. www.cdc.gov/
niosh/docs/2004-165/pdfs/2004-165.pdf
Antineoplastic drugs American Society of Health-System Pharmacists (ASHP) guidelines for handling hazardous drugs. www.ashp.org/
doclibrary/bestpractices/prepgdlhazdrugs.aspx
NIOSH alert on preventing occupational exposures to antineoplastic and other hazardous drugs. http://
www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf
OSHA Technical Manual (OTM) Section VI: Chapter 2: Controlling occupational exposure to hazardous drugs 
https://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html
Occupational Safety and Health Administration (OSHA) safety and health topic page: Hazardous drugs. https://
www.osha.gov/SLTC/index.html
Chemical sterilants OSHA Standard 1910.1047 ethylene oxide. http://www.osha.gov/pls/oshaweb/owadisp.show_document?
p_table=standards&p_id=10070
OSHA. Ethylene Oxide (EtO): Understanding OSHA's exposure monitoring requirements. https://www.osha.gov/
Publications/OSHA_ethylene_oxide.pdf
NIOSH. Current intelligence bulletin no. 52: Ethylene oxide sterilizers health care facilities-engineering controls 
and work practices. http://www.cdc.gov/niosh/docs/89-115/
High level disinfectants NIOSH. Glutaraldehyde: Occupational hazards in hospitals. http://www.cdc.gov/niosh/docs/2001-115/
OSHA. Best practices for the safe use of glutaraldehyde in health care. https://www.osha.gov/Publications/
3258-08N-2006-English.html
NIOSH Evaluation of worker exposures to peracetic acid-based sterilant during endoscope reprocessing. 
www.cdc.gov/niosh/hhe/reports/pdfs/2006-0298-3090.pdf
Surgical smoke NIOSH hazard controls: Control of smoke from laser/electric surgical procedures http://www.cdc.gov/niosh/docs/
hazardcontrol/hc11.html
OSHA surgical suite eTool. https://www.osha.gov/SLTC/etools/hospital/surgical/surgical.html
AORN management of surgical smoke tool kit. http://www.aorn.org/smoketoolkit/
Information alert: Laser plume in surgical procedures. http://www.ccohs.ca/otherhsinfo/alerts/alert61.txt
OSHA safety and health topics: Laser/electrosurgery plume. https://www.osha.gov/SLTC/laserelectrosurgeryplume/
Information Alert: Laser plume in surgical procedures. http://www.ccohs.ca/otherhsinfo/alerts/alert61.txt
Anesthetic gases OSHA Technical Manual (OTM) Section VI: Chapter 1: Hospital investigations: Health hazards. https://
www.osha.gov/dts/osta/otm/otm_vi/otm_vi_1.html
OSHA. Anesthetic gases: Guidelines for workplace exposures. 2000. https://www.osha.gov/dts/osta/
anestheticgases/index.html
NIOSH. Controlling exposures to nitrous oxide during anesthetic administration. http://www.cdc.gov/niosh/docs/
94-100/
NIOSH. Control of nitrous oxide in dental operatories. http://www.cdc.gov/niosh/docs/hazardcontrol/hc3.html
NIOSH. Waste anesthetic gases—Occupational hazards in hospitals. http://www.cdc.gov/niosh/docs/2007-151/pdfs/
2007-151.pdf
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